Adoptive T cell therapy of cancer

Current Opinion in Immunology

Volumn 21, Issue 2, 2009, Pages 187-189

  Schumacher, Ton NM ^a   Restifo, Nicholas P ^b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ADOPTIVE IMMUNOTHERAPY; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; EDITORIAL; EFFECTOR CELL; GENETIC ENGINEERING; HUMAN; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

ANIMALS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; NEOPLASMS; T-LYMPHOCYTES;

EID: 65249119290     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.03.006     Document Type: Editorial

References (14)

1. Willimsky G., and Blankenstein T. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437 (2005) 141-146
2. Dudley M.E., Wunderlich J.R., Robbins P.F., Yang J.C., Hwu P., Schwartzentruber D.J., Topalian S.L., Sherry R., Restifo N.P., Hubicki A.M., et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298 (2002) 850-854
3. Schumacher T.N. T-cell-receptor gene therapy. Nat Rev Immunol 2 (2002) 512-519
4. Review by Offringa R. Antigen choice in adoptive T cell therapy of cancer. Curr Opin Immunol 21 (2009) 190-199
5. Lamers C.H., Sleijfer S., Vulto A.G., Kruit W.H., Kliffen M., Debets R., Gratama J.W., Stoter G., and Oosterwijk E. Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. J Clin Oncol 24 (2006) e20-22
6. Berger C., Turtle C.R., Jensen M.C., and Riddell S.R. Adoptive transfer of virus-specific and tumor-specific T cell immunity. Curr Opin Immunol 21 (2009) 224-232
7. Berger C., Jensen M.C., Lansdorp P.M., Gough M., Elliott C., and Riddell S.R. Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates. J Clin Invest 118 (2008) 294-305
8. Muranski P., and Restifo N.P. Adoptive immunotherapy of cancer using CD4+ T cells. Curr Opin Immunol 21 (2009) 200-208
9. Hunder N.N., Wallen H., Cao J., Hendricks D.W., Reilly J.Z., Rodmyre R., Jungbluth A., Gnjatic S., Thompson J.A., and Yee C. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med 358 (2008) 2698-2703
10. Sadelain M., Brentjens R., and Riviere I. The promise and potential pitfalls of chimeric antigen receptors for cancer therapy. Curr Opin Immunol 21 (2009) 215-223
11. Bendle G.M., Haanen J.B., and Schumacher T.N. Preclinical development of T cell receptor gene therapy. Curr Opin Immunol 21 (2009) 209-214
12. Eshhar Z., Waks T., Gross G., and Schindler D.G. Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors. Proc Natl Acad Sci U S A 90 (1993) 720-724
13. Dudley M.E., and Rosenberg S.A. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol 21 (2009) 233-240
14. Gattinoni L., Powell Jr. D.J., Rosenberg S.A., and Restifo N.P. Adoptive immunotherapy for cancer: building on success. Nat Rev Immunol 6 (2006) 383-393